REL Publication | Stabilizing School Performance Indicators in New Jersey to Reduce the Effect of Random Error

The Every Student Succeeds Act of 2015 requires states to use a variety of indicators, including standardized tests and attendance records, to designate schools for support and improvement based on schoolwide performance and the performance of groups of students within schools. Schoolwide and group-­level performance indicators are also diagnostically relevant for district-­level and school-level decisionmaking outside the formal accountability context. Like all measurements, performance
indicators are subject to measurement error, with some having more random error than others. Measurement error can have an outsized effect for smaller groups of students, rendering their measured performance unreliable, which can lead to misidentification of groups with the greatest needs. Many states address the reliability problem by excluding from accountability student groups smaller than an established threshold, but this approach sacrifices equity, which requires counting students in all relevant groups.

With the aim of improving reliability, particularly for small groups of students, this study applied a stabilization model called Bayesian hierarchical modeling to group-­level data (with groups assigned according to demographic designations) within schools in New Jersey. Stabilization substantially improved the reliability of test-­based indicators, including proficiency rates and median student growth percentiles. The stabilization model used in this study was less effective for non-­test-based indictors, such as chronic absenteeism and graduation rate, for several reasons related to their statistical properties. When stabilization is applied to the indicators best suited for it (such as proficiency and growth), it leads to substantial changes in the lists of schools designated for support and improvement. These results indicate that, applied correctly, stabilization can increase the reliability of performance indicators for processes using these indicators, simultaneously improving accuracy and equity.

Online Availability

Source link

Visited 1 times, 1 visit(s) today

Related Article

Concept Medical 宣佈 MAGICAL BTK IDE 試驗的首位病人入院,在美國啟動 PAD 臨床計劃 | 全球企業動態 | 商情

佛羅里達州坦帕2025年1月18日 /美通社/ — 全球創新藥物輸送科技領域的先鋒概念醫療公司 Concept Medical Inc 自豪地宣佈,「MAGICAL BTK」(經皮血管腔內成形術 (MagicTouch PTA) – Sirolimus 塗層球囊 (Sirolimus Coated Balloon) 與標準球囊血管成形術治療膝部以下 (BTK) 動脈疾病的隨機對照試驗)臨床試驗器材豁免 (IDE) 中樞試驗,成功招募了首位病人。Icahn School of Medicine at Mount Sinai 的 Prakash Krishnan 醫生和其團隊招募了首位病人,標誌著膝下周邊動脈疾病 (PAD) 病人治療方案發展的重要里程碑。 First patient enrollment in MAGICAL-BTK IDE Study in the United States. 在美國食品和藥物管理局 (FDA) 最近獲得 MagicTouch PTA 的 IDE 批准後,這次成功招募病人,預示著 Concept Medical 在美國的周邊臨床試驗計劃正式開始。由於

0
Would love your thoughts, please comment.x
()
x